Traffic Roots Pixel
 

CBD

Will hype keep driving up CBD investments over THC?

Posted on October 25th, 2018 by Global Ganja Report and tagged , , , , , , , , , .

cannabisAmid the seemingly endless hype about CBD, its once better-known sibling cannabinoid THC seems to increasingly languish in the shadows—both in terms of media attention and industry investment.

Cannabis at issue in several states for midterm elections

leafVoters in several states will cast ballots on cannabis-related measures in the Nov. 6 midterm election. Michigan and North Dakota are facing general legalization measures, while Utah and Missouri voters will get to weigh in on medical marijuana.

Industry leader Justin Cooper speaks on Canada's cannabis future —and the world's

Posted on October 11th, 2018 by Bill Weinberg and tagged , , , , , , , , , .

Justin CooperJustin Cooper is co-founder and CEO of British Columbia-based Green Planet, which supplies equipment to all of Canada's Licensed Producers of cannabis as well as producing its own line of fertilizers. He speaks with Cannabis Now about the fast-growing legal industry in his country, and what it means for the world.

Mother Courage in Peru

Posted on October 3rd, 2018 by Bill Weinberg and tagged , , , , , , , .


The woman behind the South American nation's new medical marijuana law may yet face prison time. Her crime? Providing the only medicine that worked for her ailing son.

In the working-class Lima district of Pueblo Libre, I make my way to an apartment complex and up to the flat of Ana Álvarez—the unlikely woman almost singly responsible for Peru’s groundbreaking new medical marijuana law.

In a bedroom, 18-year-old Anthony watches a noisy Spiderman movie, occasionally interrupting through the open door as I chat with his mom in the living room. Anthony suffers from tuberous sclerosis, a severe form of epilepsy, and was the voiceless central figure behind the events that led to a major reform of Peru’s drug laws in 2017.

FDA called for de-scheduling of CBD: report

Posted on October 3rd, 2018 by Global Ganja Report and tagged , , , , , , , .

cannabisLast month, the DEA enthused the pharmaceutical industry but disappointed cannabis advocates by re-scheduling the drug Epidiolex—but not CBD, the cannabinoid that makes it work. Now word emerges of a letter to the DEA by the Food & Drug Administration essentially calling for the descheduling of CBD altogether.

California passes cannabis equity law

Posted on October 2nd, 2018 by Global Ganja Report and tagged , , , , , , , , , , , , .

CaliforniaAmong several cannabis-related bills signed into law by California's Gov. Jerry Brown was one creating an "equity" program for the state's legalized industry. aimed at justice and inclusion for those communities hardest hit by marijuana prohibition. Another measure will erase past convictions for possession of cannabis in quantities that are now legal.

DEA reschedules Epidiolex —but not CBD

Posted on September 27th, 2018 by Global Ganja Report and tagged , , , , , , , , .

EpidiolexWith the DEA's rescheduling of Epidiolex, shares in the British manufacturer of the drug are soaring. But CBD—the actual cannabinoid that the product is based on—is to remain in the restrictive Scheudle 1.

Vancouver 'harm reduction' raid foreboding sign in countdown to Canadian legalization

Posted on September 21st, 2018 by Global Ganja Report and tagged , , , , , , , .

CanadaA Vancouver police raid on a "harm reduction center" that was selling cannabis products raises uneasy questions about the availability of cannabis in British Columbia when Canadian legalization officially hits in next month. With only one retail outfit likely to be licensed province-wide and authorities pledging a crackdown on the old dispensaries, the ironic reality may be cannabis will initially be harder to get in BC once it is "legal."

Who's new

  • Baba Israel
  • Karr Young
  • John Veit
  • YosephLeib
  • Peter Gorman